- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 491/107 - Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
Patent holdings for IPC class C07D 491/107
Total number of patents in this class: 2131
10-year publication summary
|
162
|
128
|
135
|
178
|
187
|
197
|
215
|
217
|
206
|
95
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Novartis AG | 10904 |
61 |
| Hoffmann-La Roche Inc. | 3379 |
44 |
| VALO Health, Inc. | 172 |
44 |
| F. Hoffmann-La Roche AG | 7926 |
38 |
| Merck Sharp & Dohme LLC | 3741 |
36 |
| Bristol-myers Squibb Company | 4892 |
35 |
| Merck Patent GmbH | 5850 |
34 |
| Takeda Pharmaceutical Company Limited | 2704 |
34 |
| Gilead Sciences, Inc. | 2028 |
29 |
| Kala bio, Inc. | 45 |
26 |
| Vertex Pharmaceuticals Incorporated | 1596 |
24 |
| Amgen Inc. | 4047 |
22 |
| Boehringer Ingelheim International GmbH | 4704 |
19 |
| Shionogi & Co., Ltd. | 867 |
18 |
| Bayer AG | 3299 |
17 |
| Bayer Pharma AG | 1061 |
17 |
| Epizyme, Inc. | 370 |
17 |
| Genentech, Inc. | 3961 |
16 |
| AstraZeneca AB | 2928 |
16 |
| The Broad Institute, Inc. | 1785 |
15 |
| Other owners | 1569 |